Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28363768 | 0.92 | — | — | |
| SCHEMBL36734 | 0.89 | FDPS (0.32) | FDPS | |
| SCHEMBL9081281 | 0.80 | — | — | |
| SCHEMBL11037852 | 0.79 | SPHK1 (0.31) | FDPS | |
| SCHEMBL6664360 | 0.78 | — | — | |
| SCHEMBL8677315 | 0.76 | FDPS (0.32) | FDPS | |
| SCHEMBL10226715 | 0.75 | TSHR (0.33) | — | |
| Acrylic Acid SCHEMBL227182 | 0.74 | LMNA (0.34) | — | |
| Methacrylic Acid SCHEMBL26673754 | 0.74 | TSHR (0.33) | — | |
| Methacrylic Acid SCHEMBL1618251 | 0.74 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1309600-B1 | PROCESS FOR THE PREPARATION OF HINDERED PHOSPHITES | CROMPTON CORP (US) | 2004-08-25 | — | — | EP | disclosed |
| US-6773624-B2 | REACTING GLYCOL SUCH AS PENTAERYTHRITOL WITH PHOSPHORUS TRIHALIDE TO PRODUCE HALO PHOSPHITE ESTER OF GLYCOL, REACTING PRODUCT WITH A PHENOL, REACTING SECOND PRODUCTS COMPRISING ORGANIC PHOSPHITE AND HALO PHOSPHITE WITH METAL PHENOLATE | CROMPTON CORPORATION | 2004-08-10 | — | — | US | disclosed |
| EP-1309600-A1 | PROCESS FOR THE PREPARATION OF HINDERED PHOSPHITES | GENERAL ELECTRIC COMPANY (US) | 2003-05-14 | — | — | EP | disclosed |
| US-20020193620-A1 | Process for the preparation of hindered phosphites | GENERAL ELECTRIC CO. | 2002-12-19 | — | — | US | disclosed |
| US-6426429-B1 | REACTING A GLYCOL WITH A PHOSPHORUS TRI-HALIDE, REACTING THE HALO PHOSPHITE ESTER PRODUCT WITH A PHENOL, AND FURTHER REACTING ITS PRODUCT WITH A METAL PHENOLATE | GENERAL ELECTRIC COMPANY | 2002-07-30 | — | — | US | disclosed |
| WO-2002014335-A1 | PROCESS FOR THE PREPARATION OF HINDERED PHOSPHITES | GENERAL ELECTRIC COMPANY (US) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193620-A1 | Process for the preparation of hindered phosphites | PTEN, PTPRS, INPPL1 | FDPS 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.